Risk of progression and the cause of mortality at chronic viral mixed-hepatitis

Aim of investigation. To estimate risk of development of liver function decompensation, hepatocellular carcinoma (HCC) development and prognostic factors of liver-related mortality in patients with chronic viral mixed-hepatitis.Material and methods. 82 patients with hepatitis D, 56 – with hepatitis...

Full description

Saved in:
Bibliographic Details
Main Authors: K. I. Yesmembetov, D. T. Abdurakhmanov, A. V. Odintsov, N. A. Mukhin
Format: Article
Language:Russian
Published: Gastro LLC 2013-07-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/1204
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860195631038464
author K. I. Yesmembetov
D. T. Abdurakhmanov
A. V. Odintsov
N. A. Mukhin
author_facet K. I. Yesmembetov
D. T. Abdurakhmanov
A. V. Odintsov
N. A. Mukhin
author_sort K. I. Yesmembetov
collection DOAJ
description Aim of investigation. To estimate risk of development of liver function decompensation, hepatocellular carcinoma (HCC) development and prognostic factors of liver-related mortality in patients with chronic viral mixed-hepatitis.Material and methods. 82 patients with hepatitis D, 56 – with hepatitis B+C and 20 – with hepatitis B+C+D, followed-up from Jan 2002 to Dec 2011, were included in the study. Results. During follow-up, decompensation occurred in 45.1, 8.9 and 62.5% of patients with compensated liver cirrhosis in groups D, BC and BCD, respectively. The 5-year risk of decompensation was 62%, 27% and 60%. HCC developed in 5.7% of patients, high AFP being the only predictor of HCC. The 5-year risk of HCC was 3.8%, 3.5% and 0%, respectively. 17.1%, 1.8% and 20% of patients died in groups D, BC and BCD, respectively, 5-year survival rate was 90%, 97% and 82%.Conclusions. In patients with chronic viral mixed hepatitis it is decompensation with liver failure development that determines prognosis and is principal cause of liver-related mortality in the most cases, not HCC development.
format Article
id doaj-art-5c236220d33544cfada1496914c77448
institution Kabale University
issn 1382-4376
2658-6673
language Russian
publishDate 2013-07-01
publisher Gastro LLC
record_format Article
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
spelling doaj-art-5c236220d33544cfada1496914c774482025-02-10T16:14:32ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732013-07-012334955788Risk of progression and the cause of mortality at chronic viral mixed-hepatitisK. I. Yesmembetov0D. T. Abdurakhmanov1A. V. Odintsov2N. A. Mukhin3State educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian FederationState educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian FederationState educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian FederationState educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian FederationAim of investigation. To estimate risk of development of liver function decompensation, hepatocellular carcinoma (HCC) development and prognostic factors of liver-related mortality in patients with chronic viral mixed-hepatitis.Material and methods. 82 patients with hepatitis D, 56 – with hepatitis B+C and 20 – with hepatitis B+C+D, followed-up from Jan 2002 to Dec 2011, were included in the study. Results. During follow-up, decompensation occurred in 45.1, 8.9 and 62.5% of patients with compensated liver cirrhosis in groups D, BC and BCD, respectively. The 5-year risk of decompensation was 62%, 27% and 60%. HCC developed in 5.7% of patients, high AFP being the only predictor of HCC. The 5-year risk of HCC was 3.8%, 3.5% and 0%, respectively. 17.1%, 1.8% and 20% of patients died in groups D, BC and BCD, respectively, 5-year survival rate was 90%, 97% and 82%.Conclusions. In patients with chronic viral mixed hepatitis it is decompensation with liver failure development that determines prognosis and is principal cause of liver-related mortality in the most cases, not HCC development.https://www.gastro-j.ru/jour/article/view/1204mixed-hepatitiscombined hepatitisliver cirrhosishepatocellular carcinomadecompensationhepatitis bhepatitis chepatitis delta
spellingShingle K. I. Yesmembetov
D. T. Abdurakhmanov
A. V. Odintsov
N. A. Mukhin
Risk of progression and the cause of mortality at chronic viral mixed-hepatitis
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
mixed-hepatitis
combined hepatitis
liver cirrhosis
hepatocellular carcinoma
decompensation
hepatitis b
hepatitis c
hepatitis delta
title Risk of progression and the cause of mortality at chronic viral mixed-hepatitis
title_full Risk of progression and the cause of mortality at chronic viral mixed-hepatitis
title_fullStr Risk of progression and the cause of mortality at chronic viral mixed-hepatitis
title_full_unstemmed Risk of progression and the cause of mortality at chronic viral mixed-hepatitis
title_short Risk of progression and the cause of mortality at chronic viral mixed-hepatitis
title_sort risk of progression and the cause of mortality at chronic viral mixed hepatitis
topic mixed-hepatitis
combined hepatitis
liver cirrhosis
hepatocellular carcinoma
decompensation
hepatitis b
hepatitis c
hepatitis delta
url https://www.gastro-j.ru/jour/article/view/1204
work_keys_str_mv AT kiyesmembetov riskofprogressionandthecauseofmortalityatchronicviralmixedhepatitis
AT dtabdurakhmanov riskofprogressionandthecauseofmortalityatchronicviralmixedhepatitis
AT avodintsov riskofprogressionandthecauseofmortalityatchronicviralmixedhepatitis
AT namukhin riskofprogressionandthecauseofmortalityatchronicviralmixedhepatitis